The existing body of evidence is not convincing that PCT adds anything beyond what other, cheaper biomarkers (like C-reactive protein) or clinical assessment can provide for management of paediatric pneumonia. The gene discussed is CRP; the disease is susceptibility to pneumonia measurement.